Evolution of the Average Target: BlossomHill Therapeutics, Inc.

Evolution of the Average Target - BlossomHill Therapeutics, Inc.

Evolution of the Target Price: BlossomHill Therapeutics, Inc.

Evolution of the Target Price - BlossomHill Therapeutics, Inc.

Changes in Analyst Recommendations: BlossomHill Therapeutics, Inc.

223b452e95a3ab09.rzHr8POiVA_rr_glAA7ANNjn3mwTRPkVIqlyFSXs2YQ.2Vu0mqfUHHe72awXbjeWVoekvwJ-FdRzEYQ3Z1yrhr2dbr-xx5AMSbnpsQ~efece09d4c67f416dfbcd34b520a7d48

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
- - +131.98%
+24.45%
+37.29%
+17.78%
+13.35%
+33.93%
+23.91%
+48.97%
+20.17%
+31.29%
Average +38.31%
Weighted average by Cap. +27.34%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
14.98USD
Average target price
35.40USD
Spread / Average Target
+136.32%
High Price Target
40.00USD
Spread / Highest target
+167.02%
Low Price Target
30.00USD
Spread / Lowest Target
+100.27%

Analyst Consensus Detail

Analyst consensus - BlossomHill Therapeutics, Inc.

Consensus revision (last 18 months)

Consensus revision (last 18 months) - BlossomHill Therapeutics, Inc.
  1. Stock Market
  2. Stocks
  3. BLSM Stock
  4. Consensus BlossomHill Therapeutics, Inc.